Friday, August 28, 2026
Home Tags Pharma commercialization

Tag: pharma commercialization

Hourglass illustrating the IRA small molecule nine-year timeline compared with the 13-year biologics timeline for Medicare drug price negotiations.

Nine Years or Thirteen? The IRA Timeline That’s Changing Pharma Marketing...

Donna Pacheco -
0
Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

Donna Pacheco -
0
Young adult standing at a crossroads between pediatric and adult healthcare, symbolizing the transition to independent care and the importance of a patient lifecycle strategy.

The 18th Birthday Cliff: The Marketing Problem Pharma Isn’t Talking About

Donna Pacheco -
0
Healthcare provider reviewing electronic health records with diagnostic coding data and digital patient analytics on a computer dashboard.

Decoding the Funnel: Why Better Diagnostic Coding May Be Pharma’s Next...

Donna Pacheco -
0
Physician evaluating treatment options while reviewing clinical evidence before prescribing a new pharmaceutical therapy.

Why Most Doctors Don’t Prescribe the “Best” Drug First

Donna Pacheco -
0
Healthcare professionals managing patient flow in a busy infusion center, illustrating healthcare capacity challenges affecting patient access to innovative therapies.

The Capacity Crisis: Why Great Drugs Still Can’t Reach Patients

Donna Pacheco -
0
Doctor reviewing AI-generated synthetic control arm clinical trial data on a transparent digital interface to evaluate evidence for pharmaceutical decision-making.

The In-Silico Sell: Can Pharma Convince Doctors to Trust AI-Generated Clinical...

Donna Pacheco -
0
Pharmaceutical market access professionals reviewing health technology assessment data, reimbursement models, and value-based pricing strategies during a strategic planning meeting.

The New Pricing Gatekeeper: Why HTA Is Becoming Pharma’s Biggest Marketing...

Donna Pacheco -
0
Physician reviewing prescription medications during a medication review to determine which therapies should remain as part of a de-prescribing pharma strategy.

De-Prescribing Pharma Strategy: What Happens When Your Drug Makes the Cut...

Donna Pacheco -
0
Healthy woman protected by a medical shield, illustrating a prevention marketing strategy for preventive pharmaceutical therapies and long-term health.

The Healthy Patient Paradox: How Do You Market a Drug to...

Donna Pacheco -
0
123Page 1 of 3
- Advertisement -

EDITOR PICKS

POPULAR POSTS

RECENT POSTS

POPULAR CATEGORY

© 2026. Pharma Marketing Network. All rights reserved.